Director Clinical Pharmacology
GlaxoSmithKline
Dr Georgios Vlasakakis PhD, is currently a Director of Clinical Pharmacology at GlaxoSmithKline in the department of Clinical Pharmacology Modelling and Simulation. He earned his PhD from the University of Cambridge and completed his postdoctoral studies at GlaxoSmithKline where he has been employed since then. During his 14-year tenure at GlaxoSmithKline Georgios has supported clinical development programs in many therapeutic areas including Metabolic, Immuno-inflammation, Global Health, and Oncology and his work involved both small and large molecules as well as early and late – stage programs.
He has published multiple original research papers in this area and has presented his research at various pharmacology and pharmacometrics meetings.
Georgios has been a member of ASCPT since 2010 and has actively served on community and network leadership initiatives and scientific programming committees. Since March 2022 Georgios has been the Vice-Chair in ASCPT’s Global Health community.
Friday, March 24, 2023
3:00 PM – 4:00 PM EDT